[Table/Fig-3]:
Correlation between vaspin and other variables among study population.
| Parameter | Type 2 Diabetes Mellitus patients TOTAL (N= 82) | Type 2 Diabetes Mellitus patients without acute coronary syndrome (Control, N= 41) | Type 2 Diabetes mellitus patients with acute coronary syndrome (Cases, N=41) | |||
|---|---|---|---|---|---|---|
| r values | p-value | r values | p-value | r values | p-value | |
| Age | -0.294 | 0.007 | 0.038 | 0.813 | 0.008 | 0.960 |
| Weight | 0.189 | 0.089 | -0.103 | 0.522 | 0.150 | 0.349 |
| Height | -0.104 | 0.352 | -0.031 | 0.847 | -0.033 | 0.838 |
| Waist circumference | -0.575 | 0.0001 | -0.146 | 0.362 | 0.066 | 0.682 |
| Hip Circumference | -0.569 | 0.0001 | -0.146 | 0.362 | 0.294 | 0.062 |
| Waist- Hip ratio | 0.315 | 0.003 | 0.122 | 0.447 | -0.152 | 0.343 |
| Body mass Index | 0.156 | 0.161 | -0.007 | 0.965 | 0.112 | 0.485 |
| Systolic blood pressure | -0.433 | 0.0001 | 0.077 | 0.632 | 0.131 | 0.414 |
| Diastolic blood pressure | -0.276 | 0.012 | 0.251 | 0.113 | -0.003 | 0.985 |
| Duration of Diabetes | -0.399 | 0.001 | -0.182 | 0.254 | 0.055 | 0.733 |
| Fasting plasma glucose | 0.112 | 0.316 | -0.073 | 0.650 | -0.039 | 0.809 |
| Total Cholesterol | - 0.099 | 0.376 | -0.172 | 0.282 | -0.025 | 0.877 |
| Triglyceride | 0.120 | 0.282 | 0.013 | 0.935 | -0.077 | 0.632 |
| HDL-C | -0.191 | 0.085 | 0.112 | 0.485 | -0.127 | 0.429 |
| LDL-C | -0.075 | 0.503 | -0.248 | 0.118 | 0.047 | 0.770 |
| VLDL-C | 0.115 | 0.303 | 0.010 | 0.950 | -0.086 | 0.593 |
| CK-Total | - 0.475 | 0.0001 | -0.378 | 0.014 | -0.143 | 0.372 |
| CK-MB | -0.407 | 0.0001 | 0.008 | 0.960 | -0.020 | 0.901 |
| Urea | -0.299 | 0.006 | -0.268 | 0.090 | 0.012 | 0.940 |
| Creatinine | -0.142 | 0.203 | -0.136 | 0.340 | 0.133 | 0.407 |
HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; VLDL-C, very low-density lipoprotein cholesterol; CK-total, creatine Kinase-total; CK-MB, creatine kinase-MB